Figures
Abstract
Sarcopenia is the age-related loss of muscle mass and function. India has 8.6% of the global elderly (>60 years) population, and this is expected to increase to 20% by 2050. Around 70% of Indians live in rural areas where lifestyle factors like diet and physical activity differ from urban areas. Understanding age, sex and location-specific sarcopenia prevalence in India is crucial. Thus, our aim was to assess the prevalence and determinants of sarcopenia in urban and rural community-dwelling men and women aged 40 years and older, representing the next generation of older Indian adults. This cross-sectional study included 745 adults (400 women) from urban and rural areas near Pune, Western India. Assessments included socio-demography, diet by-24-hr recall, physical activity, anthropometry (height, weight), muscle mass measurement by dual-energy X-ray absorptiometry, muscle strength (hand grip) & muscle function by Short Physical Performance Battery (SPPB). Sarcopenia was defined by Asian Working Group on Sarcopenia-2019 guidelines Mean age of participants was 53±7.6yrs. Overall prevalence of sarcopenia was 10% and of severe sarcopenia was 4.2%. Sarcopenia prevalence was higher in rural (14.8%) than urban (6.8%) participants and in men (12.5%) than women (8%, all p<0.05). Muscle mass, grip strength and SPPB score were all higher in urban than rural participants (p<0.05). Older age, rural residence, inadequate protein intake, and lower socio-economic status were independently associated with sarcopenia. In this middle-aged group, sarcopenia prevalence was similar to that observed in older Western populations, over 100% higher among rural than urban participants, and higher amongst men than women. Age, location, protein intake and socioeconomic status were factors associated with sarcopenia. Given this rapidly increasing population of older adults in India there is an urgent need to plan strategies for early sarcopenia diagnosis and management, especially in rural populations.
Citation: Bhat G, Ireland A, Shah N, Gondhalekar K, Mandlik R, Kajale N, et al. (2024) Prevalence and factors associated with sarcopenia among urban and rural Indian adults in middle age: A cross-sectional study from Western India. PLOS Glob Public Health 4(10): e0003553. https://doi.org/10.1371/journal.pgph.0003553
Editor: Zulkarnain Jaafar, Universiti Malaya, MALAYSIA
Received: May 7, 2024; Accepted: August 8, 2024; Published: October 1, 2024
Copyright: © 2024 Bhat et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The original data for this are available from: https://doi.org/10.6084/m9.figshare.25434382.v1.
Funding: The authors received no specific funding for this work.
Competing interests: The authors have declared that no competing interests exist.
Introduction
During the human ageing process, there is a progressive decline in skeletal muscle mass and function, a condition known as sarcopenia [1–3]. There is approximately a 30% loss of muscle mass between the ages of 20–80 years [3]. Sarcopenia leads to a decline in functional capacity, increased risk of falls and fractures, physical disability, increased frailty syndrome, poor quality of life and even premature death [3, 4]. Due to these adverse outcomes, sarcopenia is a major public health problem, recognition of which is indicated by the assignment of an International Classification of Diseases (ICD-10-Rev:10,2016) code for sarcopenia [5].
The aetiology of sarcopenia is multifactorial including factors like age, socio-demography, lifestyle, genetic, hormonal, and certain health conditions [2, 6]. Muscle mass decreases at an annual rate of approximately 1–2% and muscle strength declines at 1.5%, with losses increasing after age 60 with a higher rate reported in sedentary individuals and in men than women [7]. This indicates that men and women show different trajectories of decline in muscle parameters with ageing [7]. Women show an accelerated decline of muscle mass and strength around and post-menopause in part due to low serum estrogen concentrations [8]. Studies have shown that there are age-related differences in prevalence of sarcopenia and also that there are sex-specific differences in muscle loss rates among men and women indicating age and sex-specific risk factors exist among sarcopenic individuals [9]. Hence, understanding of sex- and age-specific sarcopenia risk is crucial for interventions and healthcare planning.
Asia is the fastest ageing region in the world. The proportion of Asian citizens over 60 years is expected to increase to 10% by 2025 and 19% by 2050 and in the coming years, sarcopenia will have a greater impact on Asian populations than other regions [10]. India has the second highest elderly (>60 years) population in the world with 8.6% of the global share in 2011, this is expected to increase to 20% by the year 2050 [11]. Around 71% of the population in India live in rural areas, where important risk factors for sarcopenia including poor diet and physical inactivity differ from urban areas [12].
Due to rapid demographic and epidemiological transition and urbanization, complex changes are occurring in the lifestyles in most of the developing world, including India [13]. Although Asian populations have a more physically active lifestyle than in western populations, they have a relatively smaller body size, higher adiposity, and lower muscle mass [14]. Further to this, there are substantial differences in socio-economic environment, lifestyle factors and health-care resources between urban-rural areas [15]. These differences influence the health outcomes of elderly, resulting in poorer outcomes in rural adults than urban ones [16]. Along with nutritional differences, physical activity levels in India have experienced a secular decline due to increasing urbanization, and economic growth [13, 14].
Given the cumulative effect of prolonged exposure to poor diet and physical inactivity, identification, and subsequent intervention with individuals at risk of sarcopenia in midlife has potential for greater improvements in later life function and health. Despite this high burden, there is limited information on sarcopenia and its determinants in middle-aged and older Indian adults, and no comparisons have been reported between urban and rural individuals. Also, due to a lack of normative data, there are challenges in diagnosis and there is likely to be an underestimation of the prevalence of sarcopenia [17–19]. There is thus a need for comprehensive community-based studies to assess the burden of the condition.
In 2019, a revised consensus by the European Working Group on Sarcopenia in Older People (EWGSOP2) was published with primary focus on low function. Participants with low muscle mass (low quantity/quality), low muscle strength and function are considered to have severe sarcopenia [20]. Similar guidelines are followed by the Asian Working Group for Sarcopenia (AWGS) which supports early identification of people at risk to enable timely intervention and promoting sarcopenia research in Asian countries by providing diagnostic cut-off values based on Asian studies [21].
Taken together, our aim was to assess the prevalence of sarcopenia in urban and rural community dwelling Indian middle-aged adults above 40 years of age. Our secondary objective was to determine modifiable factors associated with sarcopenia in this population, to identify potential opportunities for intervention.
Methods
Study design and sample size
This was a prospective, cross-sectional study conducted among urban and rural men and women above 40 years of age.
Ethical approval
This study was approved by Institutional Ethics Committee, Jehangir Clinical Development centre (JCDC)and written informed consent was obtained from all participants. (Approval date: 2/03/2020)
Based on 17% prevalence of sarcopenia reported from a global study by Tyrovolas et al [22], using the definition of sarcopenia as low skeletal muscle mass and either slow gait speed or low hand grip strength, and considering 4–5% variation among the population, a total sample size was calculated with the formula (n = Z2 * P(1-P)/e2) as 350 urban and 350 rural with 175 men and 175 women from each location.
Inclusion and exclusion criteria
Apparently healthy men and women above age 40 years and who consented to participate were included. Rural participants were recruited between 20-06-2020 and 25-02-2022, whilst urban participants were recruited between 27-05-21 and 21-03-23. Participants with present acute illness, co-morbidities like diabetes, thyroid disorders, arthritis, and chronic conditions (liver/kidney failure, cardio-vascular disease, etc.) & with major surgeries were excluded. Participants with any metal implant in their bones and women who were pregnant/lactating, who had undergone hysterectomy were excluded from the study (Fig 1).
Data on age, sex, location, socio-economic status [23], medical and reproductive history (in women) were obtained using a structured and pre-tested questionnaire (intra class correlation coefficients 0.81–0.99). Data on history of past and current illness, medications, and reproductive history in women (age at menarche, marital status, parity, age at menopause) was obtained using a structured questionnaire. Height was measured using a stadiometer (Seca-Portable stadiometer, Hamburg, Germany), weight was measured using a Bioelectrical Impedance Analyzer (BIA) weight scale, and body mass index (BMI) was calculated.
Lifestyle factors
The Global Physical Activity Questionnaire (GPAQ) [24] was adapted and validated for an Indian urban and rural population to capture physical activity data. Activities were classified as job or occupation related, household and recreational. Information about time spent in minutes for daily activities like work, household activities, exercise/recreational, sleep, sitting, travelling was obtained and activities were classified as heavy, moderate, and light activities. These activities were classified using MET scores as described in the Compendium of Physical Activity (Version-2.) [25]. The participant was considered as physically active if they performed moderate physical activity for more than 150 min/week or vigorous physical activity for more than 75 min/week as per WHO guidelines [26].
Sunlight exposure was assessed by using a validated questionnaire and was considered adequate if the participant was exposed to sunlight equivalent to >2 hours of casual sunlight exposure daily with 15% skin surface exposed between 11am- 3 pm [27].
Dietary intake was assessed by 24-hr recall by a trained investigator using standard cups and spoons. Nutrient intake was computed using C-diet software ver. 3.2 (cooked and raw food database software) [28]. As per ICMR-NIN guidelines for Nutrient Requirement for Indians, estimated Average Requirements (EAR) were referred to for intake of protein (0.66gm/kg/day i.e. 43g protein/day for men weighing 65 kg and 36g protein/day for women weighing 55kg) and participants in which protein consumption was less than EAR were referred as having inadequate protein intake [29].
Measurement of muscle parameters
AWGS-2019 recommends the use of dual-energy X-ray absorptiometry (DXA) (height adjusted) for measurement of muscle mass in sarcopenia diagnosis [20]. Hence as per the protocol, in the present study muscle mass was measured using DXA (Lunar-iDXA GE Healthcare, Encore V-16) to assess total and appendicular skeletal muscle mass (ASM) and body composition and Appendicular skeletal muscle index (ASMI-kg/m2) was calculated as ASM/ (height in m2) [30, 31].
Participants were positioned for a whole-body scan according to the manufacturer’s protocol. In order to minimize interobserver variation, all scans and analyses were carried out by the same technician and the coefficient of variation (CV) for total body lean mass was <1% [30]. The machine was calibrated by performing quality assurance (QA) checks daily.
AWGS 2019 recommends the use of hand grip strength to measure muscle strength using either a spring type (Smedley) or hydraulic type (JAMAR) hand dynamometer using standard protocols [20]. In this study, grip strength was measured using a hydraulic type hand dynamometer (JAMAR-Plus Hand dynamometer, Warrenville, IL, USA).
The American Society of Hand Therapists and the Southampton protocol recommends sitting with 90-degree elbow flexion as the standard position for measuring handgrip strength using the Jamar dynamometer [20]. A similar protocol was used in our study; the participant was seated in the upright position and the dynamometer handle was adjusted to accommodate participants’ hand size and hand grip was measured. The grip strength was measured for both hands. Three readings with a rest of 30-seconds between each reading were recorded and the average was considered for the assessment.
3. Measurement of muscle function
Published studies have used a wide range of physical performance tests which include usual gait speed test, 6m-walk test, short physical performance battery (SPPB), five-time chair-stand test etc. AWGS-2019 recommends defining low physical performance based on either SPPB, 6-m walk, or five-time chair stand test cutoffs [20].
In this study, muscle function was assessed using the Short Physical Performance Battery (SPPB) explained by Guralnik et al [32]. This includes three simple tests: the standing balance test, gait speed test and five-times chair stand test: All the tests were scored from 0 to 4 using standard thresholds and summed for a total score ranging from 0 to 12; higher scores indicate better muscle function.
Diagnosis of sarcopenia
Sarcopenia was defined as age-related loss of skeletal muscle mass and loss of muscle strength and/or reduced physical performance without any co-morbidity as per the AWGS-2019 revised guidelines. Specifically, AWGS 2019 introduces “possible sarcopenia,” defined by low muscle strength with/without reduced physical performance. To define low muscle mass, AWGS-2019 recommends use of cutoffs for low muscle mass as less than 7.0kg/m2 for men and 5.4kg/m2 for women by DXA [20].
AWGS-2019 does not propose dynamometer-specific cut-offs and recommends low muscle strength diagnostic-cut-offs of handgrip less than 28.0 kg for men and less than 18.0kg for women [20].
SPPB score ≤ 9 as the cut-off or low physical performance was used in which performance of balance test for 10 seconds, 5-timechair stand time cut-off of 12 seconds and gait speed cut-off as 0.8m/sec were used [20].
Statistical analysis
Statistical analyses were carried out using the IBM-SPSS Statistics for Windows-(version 21.0, IBM Corp, Armonk, NY, USA); study parameters were tested for normality. Continuous variables of demographic, anthropometric, muscle and lifestyle parameters between urban-rural participants were compared using T-test and categorical variables were compared by column proportions. Binary logistic regression models were used to determine factors associated with sarcopenia.
Results
Table 1 illustrates the comparison of descriptive characteristics between urban and rural men and women.
Socio-demographic characteristics
A total of 745 participants, 360 urban and 385 from rural areas participated (345 men and 400 women). There was no significant difference in age between urban and rural participants (p>0.05). There was a significant difference in the socio-economic status between urban and rural participants (p<0.05). Most of the urban participants were from the higher socio-economic class and rural participants were from lower or middle class [23].
Anthropometric parameters
Urban men and women were taller and heavier than their rural counterparts (p<0.05). Indicators of adiposity (BMI, WC) and muscle mass (MUAC & CC) were higher in the urban population (p<0.05).
Muscle parameters
Mean values of muscle parameters such as muscle mass (expressed as appendicular skeletal muscle index), grip strength and muscle function score (given by SPPB) were significantly higher among urban participants than their rural counterparts (p<0.05, Table 1).
Lifestyle parameters
Nutrient intake differed between the urban and rural participants (p<0.05). Total energy, protein, carbohydrate, and fat intake was significantly higher among urban participants than their rural counterparts. As per Indian guidelines (ICMI-NIN-2021) [29] for Estimated Average Requirement (EAR), only 29% of total participants had an adequate protein intake among which, 16% from rural (men = 21%, women = 12%) and 44% from urban (men = 39%, women = 48%) reported adequate protein intake (p<0.05). Protein adequacy did not differ significantly among men and women.
Rural men and women were involved in more moderate to heavy occupational activities (farming, animal care) than their urban counterparts, while urban men and women took part in more moderate to light physical activity (p <0.05)).
Sunlight exposure was higher in rural than urban residents (41% vs 7%) and it was reported higher in rural men (48%) than urban men (7%) and in rural women (36%) than urban women (2%) (all p<0.05).
Rural men reported higher tobacco consumption/smoking than urban men (53% vs 17%) and rural women reported higher tobacco use than urban women (38% vs 7%). (All p<0.05)
Fig 2. illustrates the prevalence of low muscle mass, low muscle strength and low muscle function among the urban-rural participants. Rural participants as compared to urban, showed a higher proportion of low muscle mass (20% vs 31%), low grip strength (67% vs 72%) and low muscle function (16% vs 31%).
MM-Muscle mass, GS- Grip Strength, MF- Muscle Function. Urban men (n = 175), Rural Men (n = 169) Urban Women (n = 182) Rural women (n = 216).
Fig 3 shows mean ASMI, grip strength and muscle function in men and women from urban and rural areas. ASMI and grip strength but not muscle function was higher in urban than rural men, whilst all three were higher in urban than rural women. For urban and rural men and rural women, greater age was associated with lower lean mass. Similar associations were observed for fat mass in rural men and women, and for bone mass in urban and rural women (all p<0.05).
(Data are presented as mean and 95%CI). Urban men (n = 175), Rural Men (n = 169) Urban Women (n = 182) Rural women (n = 216).
Prevalence of sarcopenia as per AWGS-2019 guidelines
We found that the overall prevalence of possible sarcopenia, sarcopenia and severe sarcopenia was 30.7%, 10.1%, and 4.2% respectively. Prevalence of sarcopenia and severe sarcopenia were higher in rural than urban participants (14.8% vs 5% and 6.8% vs 1.4% respectively, p<0.05 for both). Sarcopenia was also more common in men than women i.e.,12.5% vs 8% (p<0.05), although severe sarcopenia did not differ by sex (4.3% in men, 4% in women, (p>0.05).
In a subgroup analysis in which the study participants were divided into 4 subgroups as urban men, rural men and urban women, prevalence of sarcopenia was higher among rural men and women than their urban counterparts, i.e.,18.3% & 12.0% vs 6.8% & 3.3% (p<0.05). Similarly, prevalence of severe sarcopenia was higher among rural than urban men (6.5% vs 2.3%) and rural than urban women (6.9% vs 0.5%, both p<0.05). Possible sarcopenia was higher in rural than urban participants (35.1% vs 26.1%) and in men than women (27.2% vs 33.8%, both p<0.05). It was also higher among rural men than urban (36.1% vs 18.8%,) (p<0.05), but did not differ between rural and urban women (34.3% vs 33.2%) (p>0.05).
Table 2 illustrates the model derived by binary logistic regression analysis which illustrates the association of sarcopenia and its determinants among study participants. No two or three-way-interactions between age, gender and location were observed (p>0.05 for all). Among factors studied, older age (OR = 1.098, (95% CI 1.064–1.133), p = 0.001), rural residence (OR = 2.456, (95% CI 1.291–4.670), p = 0.006), inadequate protein intake (OR = 2.042, (95% CI 1.063–3.921), p = 0.032), and lower socio-economic status (OR = 2.182, (95% CI 1.313–3.627, p = 0.003) were independently associated with sarcopenia risk. Tobacco consumption, sunlight exposure and physical activity were not significantly associated with sarcopenia in the whole group (p>0.05 for all).
As prevalence of sarcopenia was higher in the rural participants we performed location-specific regression analysis to assess association of sarcopenia and related factors.
Table 3 illustrates the regression analysis model derived separately for urban and rural participants. In the urban participants, older age (OR = 1.068 (95% CI 1.007–1.133), p = 0.028) and physical inactivity (OR = 4.587, (95%CI 1.529–13.760), p = 0.007) were found to be positively associated with sarcopenia. However, in the rural participants, older age (OR = 1.112, (95% CI 1.070–1.156), p = 0.001) and lower socio-economic status (OR = 2.150, (95% CI 1.214–3.808), p = 0.009) were significantly positively associated with sarcopenia.
Discussion
Our study investigated the prevalence of sarcopenia among middle-aged, community-dwelling adults from urban and rural areas in Pune, Western India. Using AWGS-2019 criteria and DXA-derived ASMI, the total prevalence of sarcopenia was 10% and severe sarcopenia was 4.2%. Prevalence of sarcopenia increased with age, was higher in men, and was more than twice as prevalent in rural areas than urban. In addition to age and rural residence, low protein intake and lower socioeconomic status were found to be associated with sarcopenia.
Only a small number of Indian studies have examined sarcopenia in community-based studies using more accurate DXA-based measurements. Limitations of previous studies include recruitment of hospital outpatients (Rahman et al from Vellore) [17], (Sreepriya et al from Thiruvananthapuram) [33] which may not be representative of the broader population, and anthropometry-based assessments of sarcopenia (Shaikh et.al) [34] from Karnataka. Another study by Tamilselvi et al from a district from Tamilnadu South India assessed the prevalence of sarcopenia using SARC-F questionnaire [18].
Using DXA derived-ASMI and AWGS criteria, we report the total prevalence of sarcopenia as 10.2% with 6.8% in urban and 14.8% in rural areas. The most comparable study examined sarcopenia in individuals of similar age (men 53.6±6.0y, women 50.1±4.6y) using DXA and AWGS criteria, finding 27% sarcopenia incidence [19]. This was the multicentre study conducted in different cohorts across different regions of India. In a study from urban Chandigarh-(North India) in individuals aged 20-85y DXA derived ASMI and EWGSOP prevalence of sarcopenia was 3.2% although the lower incidence is likely explained by lower mean participant age (44.4±15.4y) [35].
Ours is the first study to examine prevalence of sarcopenia across urban and rural populations in India. From the Asian subcontinent, we found only two studies which have compared prevalence of sarcopenia among urban and rural populations and used less accurate anthropometry (calf circumference) [36] from China and BIA measurements [37] from Korea. Our findings of a higher prevalence of sarcopenia in rural (21.6%) than urban (6.4%) areas are similar to these limited observations. In China, Gao et al.’s study reported total prevalence of sarcopenia as 9.8% with 13.1% in rural and 7% in urban areas, using AWGS criteria and calf circumference measurement [36]. Similarly in Korea, Moon et al. found sarcopenia prevalence rates of 24.4% and 16.3%, in rural and urban participants respectively using BIA-derived ASMI and AWGS criteria [16]. In agreement with the above-mentioned studies in other Asian countries, our study showed higher prevalence of low muscle mass, low grip strength, and low muscle function in rural compared to the urban participants.
We found a higher prevalence of sarcopenia in men than women, both in urban and rural areas (6.8% and 3.3% Vs 18.3% and 12% respectively). A recent global meta-analysis including data from around 700,000 individuals had contrasting findings of sex differences in sarcopenia dependent on the diagnostic criteria used. Studies using European Working Group on Sarcopenia in Older People 2 (EWGSOP2) found higher prevalence in men than women (11% vs 2%), whereas the opposite was observed in those employing International Working Group on Sarcopenia criteria (17% vs 12%). This may reflect the latter’s use of gait speed rather than hand grip as a primary diagnostic test, which would be influenced by higher fat percentage in women [37]. Based on systematic reviews from Asia and other countries, it has been observed that sarcopenia was more common among Asian men than women [36]. A study from Vellore (India) also reported higher prevalence in men than women i.e., 47% vs 23% in an older population attending a geriatric outpatient clinic [17]. However, in contrary to our results, a South Indian study in rural individuals aged 60 and over reported higher prevalence in women than men (24.5% vs 3.4%) although this was based only on anthropometric measurement [34]. A Chinese community-based study also reported higher prevalence of 19.2% in men vs 8.6% in women [38].
A methodological contributor to our finding of higher sarcopenia prevalence in men could be the use of hand grip strength as a primary diagnostic criterion as described above. Largely, alternatively, it could relate to higher physical activity levels in the presence of low protein intake in men observed in this study, or higher levels of tobacco consumption. Hormonal differences could also contribute, namely lower levels of IGF-1 which is an important mediator of muscle growth and repair Previous work found higher IGF-1 levels among women than men at a relatively younger age. As age advanced, the IGF-1 levels did not show an age-related decline in women, however, in men, IGF-1 showed an age-related decline [39]. Similar trends were observed in a small group of Caucasian and Chinese elderly suggesting that changes in IGF-1 may contribute to observed sex differences [17].
Higher prevalence of sarcopenia in rural residents indicates populations in rural areas are more vulnerable to sarcopenia than in urban areas. Variations in demographic profiles, body composition, nutritional status, lifestyle, and other cultural practices have an influence on peak skeletal muscle mass and rate of decline of muscle mass, strength, and function [17]. These and other environmental factors like access to food and healthcare facilities are likely to contribute to observed regional differences in sarcopenia risk.
In our study, lower socioeconomic class was also associated with increased risk of sarcopenia in rural participants. Low socio-economic status could be a cause of malnutrition in rural areas due to lack of accessible food resources and purchasing ability by rural individuals. Some Indian studies have found greater risk of sarcopenia in the lower socio-economic class, concurrent with low education and malnutrition Studies from Kolkata, India [11] and China [40] report that low education and income were associated with sarcopenia.
We also found that low protein intake was associated with increased risk of sarcopenia in rural participants. A Korean study found that lower intake of protein, energy and other micronutrients increases the risk of sarcopenia and inadequate protein intake may lead to loss of muscle mass and function [41]. Several other cohort studies have also found similar associations between protein and sarcopenia [42]. Another study by Kim et al revealed that, lower protein intake led to reduced muscle protein synthesis and subsequently affects net protein balance in older adults, which may explain these associations [43].
Numerous systematic reviews and meta-analyses report that physical inactivity is a risk factor for sarcopenia. A study by Mijnarends from the Netherlands found that in physically inactive individuals, incidence of sarcopenia was significantly higher as compared to more active individuals indicating that physical inactivity hastens the onset of sarcopenia [44]. As along with low protein intake, physical inactivity results in lower muscle protein synthesis rates [45]. Despite heavy physical activity and adequate sunlight exposure, we observed higher prevalence of sarcopenia among rural residents possibly indicating that diet and socio-economic status may overshadow the impact of physical activity in determining the risk of sarcopenia.
As India’s population is ageing rapidly, it is predicted that by 2041, it will be home to around 230 million elderly people [35]. With this increasing number, sarcopenia is likely to become a major public health concern in older adults leading to increased healthcare expenditure. There is thus an urgent need to plan strategies for early diagnosis and management of sarcopenia, which can be achieved by community screening of middle-aged and older individuals with simple and cost-effective screening tools and thus improving sarcopenia by appropriate interventions related to nutrition and physical activity [46].
Our study has several strengths; the study provides insights into the problem of sarcopenia from urban and rural areas of western India. This is the first Indian study to describe urban-rural differences in prevalence and factors associated with sarcopenia. We have used DXA which is now the gold standard to derive ASMI for diagnosis of low muscle mass. In most previous community-based studies from India, BIA, anthropometry, or other measures have been used due to their feasibility and low cost. Also, we have used SPPB which is a well-established and validated tool to assess muscle function.
One of the limitations of our study is that it is cross-sectional, hence we cannot comment on the causality. Longitudinal studies are needed for establishing causal relationships between sarcopenia and associated factors. As there is a lack of normative data in Indian population there are no India-specific cut-offs on muscle parameters, Further, we did not assess biochemical parameters like vitamin D, fasting insulin, IGF-1 etc due to logistics involved.
Conclusion
This study assessed the prevalence and investigated the factors associated with sarcopenia among urban and rural Indian adults, and revealed much higher prevalence in rural individuals than their urban counterparts, and higher prevalence in men as compared to women. In this study, along with increasing age, lower socio-economic status and low protein intake were found to be significant risk factors for sarcopenia. Whilst these exposures partly explain rural-urban differences, additional influences such as lifestyle (physical activity, tobacco consumption) and other cultural factors may contribute to the remaining increased risk. Given the growing elderly population in India and increasing prevalence of sarcopenia, there is an urgent need to plan strategies for early identification, treatment, and management. Further integrated research and collaboration are required for standardization of techniques used for diagnosis of sarcopenia for achieving consistency in research in sarcopenia assessment.
Acknowledgments
We wish to express our sincere thanks to our institute-HCJMRI for support and all the participants in the study for their participation.
References
- 1. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age and ageing. 2010 Jul;39(4):412–23. pmid:20392703
- 2. Volpato S, Bianchi L, Cherubini A, Landi F, Maggio M, Savino E, et al. Prevalence and clinical correlates of sarcopenia in community-dwelling older people: application of the EWGSOP definition and diagnostic algorithm. Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences. 2014 Apr 1;69(4):438–46. pmid:24085400
- 3. Kapoor D, Piplani T, Singh A, Perwaiz A, Chaudhary A. Defining sarcopenia in the Indian population—a step forward. Indian Journal of Surgery. 2021 Apr;83:476–82.
- 4. Beaudart C, Rizzoli R, Bruyère O, Reginster JY, Biver E. Sarcopenia: burden and challenges for public health. Archives of public health. 2014 Dec;72(1):1–8.
- 5. Suetta C, Haddock B, Alcazar J, Noerst T, Hansen OM, Ludvig H, et al. The Copenhagen Sarcopenia Study: lean mass, strength, power, and physical function in a Danish cohort aged 20–93 years. Journal of cachexia, sarcopenia and muscle. 2019 Dec;10(6):1316–29. pmid:31419087
- 6. Confortin SC, Ono LM, Barbosa AR, d’Orsi E. Sarcopenia and its association with changes in socioeconomic, behavioral, and health factors: the EpiFloripa Elderly Study. Cadernos de Saúde Pública. 2018 Nov 29;34.
- 7. Rolland Y, Czerwinski S, Van Kan GA, Morley JE, Cesari M, Onder G, et al. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. The Journal of Nutrition Health and Aging. 2008 Sep;12:433–50. pmid:18615225
- 8. Rathnayake N, Alwis G, Lenora J, Lekamwasam S. Factors associated with measures of sarcopenia in pre and postmenopausal women. BMC Women’s Health. 2021 Dec; 21:1–9.
- 9. Hwang J, Park S. Gender-specific risk factors and prevalence for sarcopenia among community-dwelling young-old adults. International Journal of Environmental Research and Public Health. 2022 Jun 13;19(12):7232. pmid:35742480
- 10. Wu YH, Hwang AC, Liu LK, Peng LN, Chen LK. Sex differences of sarcopenia in Asian populations: the implications in diagnosis and management. Journal of Clinical Gerontology and Geriatrics. 2016 Jun 1;7(2):37–43.
- 11. Das S, Mukhopadhyay S, Mukhopadhyay B. Frailty syndrome and sarcopenia among rural older adults in West Bengal, India: a cross-sectional study. Asian Journal of Gerontology & Geriatrics. 2021 Dec 1;16(2).
- 12.
Elderly in India-2016. Central Statistics Office. Ministry of Statistics and Programme Implementation. Government of India. http://mospi.nic.in/sites/default/files/publication_reports/ ElderlyinIndia_2016.pdf. Accessed 29 October 2020
- 13. Shetty PS. Nutrition transition in India. Public health nutrition. 2002 Feb;5(1a):175–82. pmid:12027282
- 14. Dhar M, Kapoor N, Suastika K, Khamseh ME, Selim S, Kumar V, et al. South asian working action group on SARCOpenia (SWAG-SARCO)–A consensus document. Osteoporosis and Sarcopenia. 2022 Jun 1;8(2):35–57. pmid:35832416
- 15. Tripathy JP, Thakur JS, Jeet G, Chawla S, Jain S, Prasad R. Urban rural differences in diet, physical activity and obesity in India: are we witnessing the great Indian equalisation? Results from a cross-sectional STEPS survey. BMC public health. 2016 Dec;16:1–0
- 16. Moon SW, Kim KJ, Lee HS, Yun YM, Kim JE, Chun YJ, et al. Low muscle mass, low muscle function, and sarcopenia in the urban and rural elderly. Scientific Reports. 2022 Aug 22;12(1):14314. pmid:35995980
- 17. Rahman R, Wilson BP, Paul TV, Yadav B, Kango Gopal G, Viggeswarpu S. Prevalence and factors contributing to primary sarcopenia in relatively healthy older Indians attending the outpatient department in a tertiary care hospital: A cross‐sectional study. Aging Medicine. 2021 Dec;4(4):257–65. pmid:34964006
- 18. Selvi T, Babitha T. A study to assess the prevalence of Sarcopenia among old aged people residing in Villupuram district. International Journal of Academic Research and Health. September 2019.
- 19. Zengin A, Kulkarni B, Khadilkar AV, Kajale N, Ekbote V, Tandon N, et al. Prevalence of sarcopenia and relationships between muscle and bone in Indian men and women. Calcified Tissue International. 2021 Oct;109:423–33. pmid:33966094
- 20. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age and ageing. 2019 Jan 1;48(1):16–31. pmid:30312372
- 21. Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. Journal of the American Medical Directors Association. 2020 Mar 1;21(3):300–7. pmid:32033882
- 22. Tyrovolas S, Koyanagi A, Olaya B, Ayuso‐Mateos JL, Miret M, Chatterji S, et al. Factors associated with skeletal muscle mass, sarcopenia, and sarcopenic obesity in older adults: a multi‐continent study. Journal of cachexia, sarcopenia and muscle. 2016 Jun;7(3):312–21. pmid:27239412
- 23.
Socio-economic classification-2011, The new SEC system.
- 24.
https://www.who.int/docs/default-source/ncds/ncd-surveillance/gpaq-analysis-guide.pdf
- 25. Ainsworth BE, Haskell WL, Herrmann SD, Meckes N, Bassett DR Jr, Tudor-Locke C, et al. 2011 Compendium of Physical Activities: a second update of codes and MET values. Medicine & science in sports & exercise. 2011 Aug 1;43(8):1575–81. pmid:21681120
- 26.
WHO guidelines on physical activity and sedentary behaviour, Geneva: World Health Organization, 2020 Apr 21:1–582.
- 27. Patwardhan VG, Mughal ZM, Chiplonkar SA, Webb AR, Kift R, Khadilkar VV, et al. Duration of casual sunlight exposure necessary for adequate Vitamin D status in Indian Men. Indian journal of endocrinology and metabolism. 2018 Mar;22(2):249. pmid:29911040
- 28. Chiplonkar SA. Trends in nutrient intakes of Indian adults: Computerized diet analysis (CDiet) of cross-sectional surveys between 1998 and 2015. Current Nutrition & Food Science. 2021 May 1;17(4):423–32.
- 29.
Revised short summary report-2024, ICMR-NIN expert group on Nutrient requirements for Indians, Recommended Dietary Allowances (RDA) and Estimated Average Requirements (EAR)-2020.
- 30. Rothney MP, Martin FP, Xia Y, Beaumont M, Davis C, Ergun D, et al. Precision of GE Lunar iDXA for the measurement of total and regional body composition in nonobese adults. Journal of Clinical Densitometry. 2012 Oct 1;15(4):399–404. pmid:22542222
- 31. Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, et al. Epidemiology of sarcopenia among the elderly in New Mexico. American journal of epidemiology. 1998 Apr 15;147(8):755–63. pmid:9554417
- 32. Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. Journal of gerontology. 1994 Mar 1;49(2):M85–94. pmid:8126356
- 33. Sreepriya PR, Pillai SS, Nair AN, Rahul A, Pillai S, Nair AT. Prevalence and associated factors of sarcopenia among patients underwent abdominal CT scan in Tertiary Care Hospital of South India. Journal of Frailty, Sarcopenia and Falls. 2020 Sep;5(3):79. pmid:32885105
- 34. Shaikh N, Harshitha R, Bhargava M. Prevalence of sarcopenia in an elderly population in rural South India: a cross-sectional study. F1000Research. 2020 Mar 10;9(175):175.
- 35. Pal R, Bhadada SK, Aggarwal A, Singh T. The prevalence of sarcopenic obesity in community-dwelling healthy Indian adults-the Sarcopenic Obesity-Chandigarh Urban Bone Epidemiological Study (SO-CUBES). Osteoporosis and Sarcopenia. 2021 Mar 1;7(1):24–9. pmid:33869802
- 36. Gao L, Jiang J, Yang M, Hao Q, Luo L, Dong B. Prevalence of sarcopenia and associated factors in Chinese community-dwelling elderly: comparison between rural and urban areas. Journal of the American Medical Directors Association. 2015 Nov 1;16(11):1003–e1. pmid:26385304
- 37. Petermann‐Rocha F, Balntzi V, Gray SR, Lara J, Ho FK, Pell JP, et al.Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis. Journal of cachexia, sarcopenia and muscle. 2022 Feb;13(1):86–99. pmid:34816624
- 38. Du Y, Wang X, Xie H, Zheng S, Wu X, Zhu X, et al. Sex differences in the prevalence and adverse outcomes of sarcopenia and sarcopenic obesity in community dwelling elderly in East China using the AWGS criteria. BMC endocrine disorders. 2019 Dec;19(1):1–1.
- 39. Albani D., Batelli S., Polito L., Vittori A., Pesaresi M., Gajo G.B., et al. 2009. A polymorphic variant of the insulin-like growth factor 1 (IGF-1) receptor correlates with mae longevity in the Italian population: a genetic study and evaluation of circulating IGF-1 from the" Treviso Longeva (TRELONG)" study. BMC geriatrics, 9(1), pp.1–7.
- 40. Jeng C, Zhao LJ, Wu K, Zhou Y, Chen T, Deng HW. Race and socioeconomic effect on sarcopenia and sarcopenic obesity in the Louisiana Osteoporosis Study (LOS). JCSM clinical reports. 2018 Jul;3(2):1–8.
- 41. Seo AR, Kim MJ, Park KS. Regional differences in the association between dietary patterns and muscle strength in Korean older adults: data from the Korea National Health and Nutrition Examination Survey 2014–2016. Nutrients. 2020 May 12;12(5):1377. pmid:32408472
- 42. Ganapathy A, Nieves JW. Nutrition and sarcopenia—what do we know?. Nutrients. 2020 Jun 11;12(6):1755. pmid:32545408
- 43. Kim IY, Schutzler S, Schrader A, Spencer H, Kortebein P, Deutz NE, et al. Quantity of dietary protein intake, but not pattern of intake, affects net protein balance primarily through differences in protein synthesis in older adults. American Journal of Physiology-Endocrinology and Metabolism. 2015.
- 44. Mijnarends D. M., Koster A., Schols J. M. G. A., et al (2016). Physical activity and incidence of sarcopenia: The population-based AGES-Reykjavik Study. Age and Ageing, 45(5), 614–621. pmid:27189729
- 45. Breen L, Stokes KA, Churchward-Venne TA, Moore DR, Baker SK, Smith K, et al. Two weeks of reduced activity decreases leg lean mass and induces “anabolic resistance” of myofibrillar protein synthesis in healthy elderly. The Journal of Clinical Endocrinology & Metabolism. 2013 Jun 1;98(6):2604–12. pmid:23589526
- 46. Li ML, Zhang F, Luo HY, Quan ZW, Wang YF, Huang LT, et al. Improving sarcopenia in older adults: a systematic review and meta-analysis of randomized controlled trials of whey protein supplementation with or without resistance training. The Journal of nutrition, health and aging. 2024 Apr 1;28(4):100184.